Ground-level ozone (O~3~) and fine particulate matter \[≤ 2.5 μm in aerodynamic diameter (PM~2.5~)\] have increased substantially since preindustrial times. Although O~3~ and PM~2.5~ concentrations have increased most in industrialized areas, observations show that background concentrations have also increased in remote regions ([@b1-ehp-118-1189]; [@b26-ehp-118-1189]; [@b28-ehp-118-1189]; [@b32-ehp-118-1189]; [@b33-ehp-118-1189]). O~3~ and PM~2.5~ are associated with negative health impacts, including premature mortality (e.g., [@b16-ehp-118-1189]; [@b18-ehp-118-1189]). [@b5-ehp-118-1189] estimated that about 800,000 annual premature deaths globally, or 1.2% of all deaths, are associated with urban outdoor PM~2.5~. This was considered an underestimate because it excludes O~3~ impacts and includes only urban areas for which econometric models trained with observations were used to predict concentrations.

We estimated the global burden of human mortality due to anthropogenic O~3~ and PM~2.5~ using a global atmospheric chemical transport model (CTM). Using an atmospheric CTM allows estimation of mortality where air quality measurements are sparse, particularly in developing nations. By simulating preindustrial concentrations, we also isolated mortality due to anthropogenic pollution and avoided making assumptions for background O~3~ and PM~2.5~ concentrations. Global CTMs have been used to estimate mortalities due to long-range transport of air pollution ([@b3-ehp-118-1189]; [@b20-ehp-118-1189]; [@b35-ehp-118-1189]), future changes in emissions ([@b34-ehp-118-1189], [@b36-ehp-118-1189]), or changes in one sector's emissions ([@b7-ehp-118-1189]). CTMs have not been used previously to quantify the global burden of anthropogenic air pollution on human mortality.

Materials and Methods
=====================

We calculated mortalities associated with anthropogenic air pollution using health impact functions that relate changes in pollutant concentrations to changes in mortality. We defined anthropogenic air pollution as the geographically distributed difference between present-day (2000) and preindustrial O~3~ and PM~2.5~ concentrations, as simulated by a global CTM. Health impact functions for both O~3~ and PM~2.5~ are based on a log-linear relationship between relative risk (RR) and concentrations defined by epidemiology studies (e.g., [@b16-ehp-118-1189]; [@b18-ehp-118-1189]):
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where β is the concentration--response factor (CRF; i.e., the estimated slope of the log-linear relation between concentration and mortality) and Δ*X* is the change in concentration. The fraction of the disease burden attributable to the risk factor, the attributable fraction (AF), was defined as
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AF was multiplied by the baseline mortality rate (*y*~0~) and size of the exposed population (Pop) to yield an estimate of the excess mortalities attributable to air pollution (ΔMort):
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Disease survival time varies among populations, and we calculated years of life lost (YLL) associated with mortalities using the baseline YLL (YLL~0~) per death:

![](ehp-118-1189e4.jpg)

For O~3~, we based CRFs on the association between long-term O~3~ exposure and RR of death from respiratory disease found by [@b16-ehp-118-1189] in an American Cancer Society (ACS) cohort study of U.S. adults ≥ 30 years of age for 1977--2000. Although many daily time-series epidemiology studies demonstrate short-term O~3~-mortality impacts (e.g., [@b4-ehp-118-1189]), [@b16-ehp-118-1189] provide the first clear evidence for long-term impacts. For the two-pollutant model that controlled for PM~2.5~, a 10-ppb increase in the seasonal (April--September) average daily 1-hr maximum O~3~ (concentration range, 33.3--104.0 ppb) was associated with a 4% \[95% confidence interval (CI), 1.3--6.7%\] increase in RR of death from respiratory disease.

For PM~2.5~, we used RRs from [@b18-ehp-118-1189], which is the latest reanalysis of the ACS PM~2.5~ studies (e.g., [@b24-ehp-118-1189]) and has the largest population of the available PM~2.5~ cohort studies (e.g., [@b13-ehp-118-1189]; [@b19-ehp-118-1189]). We used RRs for 1999--2000 from the random-effects Cox model analysis that adjusted for 44 individual-level and seven ecological covariates. A 10-μg/m^3^ increase in PM~2.5~ (concentration range, 5.8--22.2 μg/m^3^) was associated with 6% (95% CI, 4--8%), 13% (95% CI, 10--16%), and 14% (95% CI, 6--23%) increases in total, cardiopulmonary, and lung cancer mortality. The linearity of the concentration--response function was also demonstrated up to 30 μg/m^3^ in the 1979--1983 analysis. [@b18-ehp-118-1189] found that PM~2.5~ was associated most strongly with risk of death from ischemic heart disease, a subset of cardiopulmonary disease, and previous studies have found that controlling for O~3~ concentrations had little effect on the PM~2.5~--mortality relationships ([@b17-ehp-118-1189]). Compared with the relationships in an earlier expert elicitation ([@b25-ehp-118-1189]), the total mortality RR in [@b18-ehp-118-1189] is generally 3--14% lower per 10-μg/m^3^ increase with a tighter CI.

We assumed that these relationships found in the United States are valid globally. For O~3~, [@b16-ehp-118-1189] is the first study showing significant long-term impacts, but the short-term impact has been well documented in North America and Europe (e.g., [@b2-ehp-118-1189]; [@b4-ehp-118-1189]). For PM~2.5~, similar long-term mortality results have been demonstrated in Europe ([@b13-ehp-118-1189]), but to date no PM~2.5~ cohort studies have been conducted in the developing world. Short-term O~3~ and PM~2.5~ studies in developing nations demonstrate relationships that are generally comparable with short-term studies in North America and Europe ([@b12-ehp-118-1189]). Our assumption is further supported by evidence that concentration--mortality relationships do not vary significantly by sex, age, and race ([@b16-ehp-118-1189]; [@b18-ehp-118-1189]; [@b41-ehp-118-1189]), although some sensitive populations may be at a higher risk. Because global causes of death differ from those in North America and Europe, we emphasized cause-specific mortality, which may have less error than estimates of all-cause mortality across different populations.

We used present-day (2000) and preindustrial O~3~ and PM~2.5~ concentrations ([Figure 1](#f1-ehp-118-1189){ref-type="fig"}) simulated by [@b14-ehp-118-1189] using the Model of Ozone and Related Chemical Tracers, version 2 (MOZART-2; [@b15-ehp-118-1189]). The preindustrial simulation, which corresponds to the 1860 simulation by [@b14-ehp-118-1189], represents the "background" O~3~ and PM~2.5~ present in the absence of anthropogenic emissions, allowing us to isolate the anthropogenic contributions to concentrations and premature mortalities. MOZART-2 has a resolution of 2.8° latitude by 2.8° longitude with 34 vertical levels, and we used concentrations in the first vertical level as surface concentrations. Both simulations used the same meteorology from the National Center for Atmospheric Research Community Climate Model to isolate the impact of emission changes on concentration. We defined PM~2.5~ as all simulated sulfate (SO~4~), nitrate (NO~3~), ammonium, black carbon (BC), and primary organic carbon (OC). We excluded dust, sea salt, and secondary organic aerosols, which we assumed are unchanged from preindustrial to present. We multiplied OC mass by 1.4 to account for associated species other than carbon, and assumed all SO~4~ and NO~3~ exists as ammonium sulfate \[(NH~4~)~2~SO~4~\] and ammonium nitrate (NH~4~NO~3~), following [@b11-ehp-118-1189]. For the preindustrial case, fossil fuel--burning emissions were set to zero and emissions from burning of biofuels, savannah, tropical forests, and agricultural waste were assumed to be 10% of 1990 values.

Consistent with the epidemiology studies, we used seasonal average 1-hr daily maximum concentrations for O~3~ and annual average concentrations for PM~2.5~. Because high O~3~ occurs during different months globally, for each grid cell, we found the consecutive 6-month period with the highest average of the simulated daily 1-hr maximum O~3~ concentrations, which we then used to calculate annual mortalities. [Table 1](#t1-ehp-118-1189){ref-type="table"} shows that the modeled global population-weighted seasonal average 1-hr daily maximum O~3~ increased by 37.1 ppb (from 19.6 ppb in 1860 to 56.7 ppb in 2000), using the present population, and the global population-weighted annual average PM~2.5~ increased by 15.0 μg/m^3^ (from 1.1 μg/m^3^ in 1860 to 16.1 μg/m^3^ in 2000). Globally, OC, BC, NO~3~, and SO~4~ are 62.3%, 6.3%, 0.3%, and 31.0% of total PM~2.5~ in 1860 and 45.6%, 9.1%, 4.9%, and 40.4% in 2000 \[see Supplemental Material, Figure 1 (doi:10.1289/ehp.0901220)\].

We compared modeled present-day surface O~3~ concentrations with data from the National Oceanic and Atmospheric Administration (NOAA) Earth Systems Research Laboratory Global Monitoring Division ([@b21-ehp-118-1189]) monitoring network (mean bias = 2.5 ppb) for 11 remote locations around the world and from three nonurban networks: the Clean Air Status and Trends Network ([@b29-ehp-118-1189]) for the United States (mean bias = 2.9 ppb), the European Monitoring and Evaluation Programme ([@b6-ehp-118-1189]) for Europe (mean bias = −0.2 ppb), and the Acid Deposition Monitoring Network in East Asia ([@b8-ehp-118-1189]) for Japan (mean bias = 0.4 ppb) \[see Supplemental Material, Figures 2--5 (doi:10.1289/ehp.0901220)\]. [@b14-ehp-118-1189] found that simulated preindustrial O~3~ concentrations overestimate reconstructed observations from the late 19th century by approximately 5--10 ppb, with strong sensitivity to assumed biomass burning. Modeled surface PM~2.5~ concentrations were compared with observations by [@b11-ehp-118-1189] and were generally found to be estimated within a factor of 2 in remote locations and at nonurban stations in Europe and the United States, with a tendency to be overestimated. These comparisons show that MOZART-2 simulates surface O~3~ and PM~2.5~ well for nonurban and remote measurements in the areas compared, and it was not apparent that corrections for bias were necessary. Although simulated concentrations were not systematically biased outside of urban regions, the coarse resolution used here (grid cell area = 9.9 × 10^4^, 8.6 × 10^4^, and 5.2 × 10^4^ km^2^ at 0°, 30°, and 60° latitude) may cause errors in mortality estimates, particularly in urban areas with strong population and concentration gradients.

We estimated global premature mortalities separately for O~3~ and PM~2.5~ by applying Equation 3 in each of the MOZART-2 surface grid cells, using the corresponding population and baseline mortality rates for each cell. To calculate mortality, we used the global 2006 population ([@b22-ehp-118-1189]) \[see Supplemental Material, Figure 6 (doi:10.1289/ehp.0901220)\], and, consistent with the ACS study population, we used the population fraction ≥ 30 years of age ([Table 1](#t1-ehp-118-1189){ref-type="table"}), estimated in 14 world regions \[[@b37-ehp-118-1189]\] \[see Supplemental Material, Figure 7 (doi:10.1289/ehp.0901220)\]. We used baseline all-cause, cardiopulmonary, and lung cancer mortality rates for 14 world regions ([@b37-ehp-118-1189]) and 66 countries ([@b38-ehp-118-1189]), back-calculating from regional rates where country-specific rates were unavailable \[[Table 1](#t1-ehp-118-1189){ref-type="table"}; see also Supplemental Material, Figures 8--11 (doi:10.1289/ehp.0901220)\]. Country-specific mortality rates are broadly categorized with no cutoff at 30 years of age, and we used rates for the population ≥ 25 years of age, assuming that differences between the rates are insignificant. We used baseline YLL rates for the population ≥ 30 years of age in 14 world regions \[global average = 7.89, 9.77, and 8.93 for cardiopulmonary disease, respiratory disease, and lung cancer; see Supplemental Material, Table 1 (doi:10.1289/ehp.0901220)\], assuming a 3% discount rate and nonuniform age weighting, giving less weight to years lived at older ages ([@b39-ehp-118-1189]). We gridded baseline mortality rates, baseline YLL, and the fraction of the population ≥ 30 years of age to the MOZART-2 grid, and for grid cells overlapping multiple countries, we calculated area-weighted averages using a geographic information system program.

We present results as means ± 1 SD, calculating uncertainty from 500 Monte Carlo simulations that randomly sampled from normal distributions of the CRF, as reported by the epidemiology studies, and modeled present-day concentrations (SD = 25% of simulated value). Although the epidemiology literature provides little evidence for low-concentration thresholds (LCTs) or high-concentration thresholds (HCTs) for either O~3~ or PM~2.5~ ([@b16-ehp-118-1189]; [@b18-ehp-118-1189]; [@b27-ehp-118-1189]), mortality relationships beyond measured concentrations are unknown. Therefore, we estimated mortalities with and without assuming LCTs below which O~3~ and PM~2.5~ are assumed to have no effect on mortality. For O~3~, we applied an LCT of 33.3 ppb, the lowest measured level in [@b16-ehp-118-1189]. When applied, this threshold replaced the natural background everywhere except in some grid cells in Asia and South America, where preindustrial concentrations exceeded the threshold ([Table 1](#t1-ehp-118-1189){ref-type="table"}). We also examined an LCT of 56 ppb, which [@b16-ehp-118-1189] found to be close to statistical significance at an α-level of 5% (*p* = 0.0600). The 56-ppb threshold exceeded preindustrial concentrations in all cells. Because no grid cells exceeded the highest measured level (104.0 ppb) in [@b16-ehp-118-1189], we did not apply an HCT for O~3~. For PM~2.5~, we applied an LCT of 5.8 μg/m^3^, the lowest measured level in [@b18-ehp-118-1189], which exceeded preindustrial concentrations in all grid cells ([Table 1](#t1-ehp-118-1189){ref-type="table"}), effectively replacing the natural background. Some grid cells in Europe and Asia exceeded the highest measured level (30.0 μg/m^3^) in [@b18-ehp-118-1189], and we examined HCTs of 30 μg/m^3^ and 50 μg/m^3^ in the sensitivity analysis. These thresholds applied only to our definition of PM~2.5~ and would be affected by including dust, sea salt, and secondary organic aerosols.

Results
=======

With no upper or lower concentration threshold, anthropogenic O~3~ was estimated to result in about 0.7 ± 0.3 million respiratory mortalities annually worldwide ([Table 2](#t2-ehp-118-1189){ref-type="table"}), corresponding to 6.3 ± 3.0 million YLL ([Table 3](#t3-ehp-118-1189){ref-type="table"}). Estimated global respiratory mortalities were reduced by approximately 33% when we assumed an LCT of 33.3 ppb, the lowest measured level in [@b16-ehp-118-1189]. Regardless of threshold assumption, \> 75% of O~3~ mortalities were estimated to occur in Asia, which is densely populated and highly polluted, whereas only approximately 5% occurred in North America. Estimated excess O~3~ mortalities were densest in highly populated areas but were distributed more evenly across the globe when divided (normalized) by population size ([Figure 2](#f2-ehp-118-1189){ref-type="fig"}).

Assuming no upper or lower concentration threshold, we estimated that exposure to anthropogenic PM~2.5~ results in 3.5 ± 0.9 million cardiopulmonary mortalities and 220,000 ± 80,000 lung cancer mortalities annually ([Table 2](#t2-ehp-118-1189){ref-type="table"}), corresponding to 28 ± 6.8 and 2.2 ± 0.8 million YLL ([Table 3](#t3-ehp-118-1189){ref-type="table"}). With an LCT of 5.8 μg/m^3^, estimated cardiopulmonary and lung cancer mortalities decreased by approximately 28%. Regardless of threshold, about 75% of excess mortalities occurred in Asia because of high PM~2.5~ concentrations and dense population, followed by Europe (17%). As for O~3~, estimated PM~2.5~ mortalities were densest in highly populated areas but more localized because of the shorter atmospheric lifetime of PM~2.5~ compared with O~3~ ([Figures 1](#f1-ehp-118-1189){ref-type="fig"}, [3](#f3-ehp-118-1189){ref-type="fig"}). The highest estimated mortalities per million people were in Europe, East Asia, and the eastern United States ([Figure 3B,D](#f3-ehp-118-1189){ref-type="fig"}), owing to large baseline cardiopulmonary and lung cancer mortality rates and high PM~2.5~ concentrations.

Applying an LCT of 25 ppb for O~3~ resulted in approximately 14% fewer estimated respiratory mortalities than when assuming no upper or lower threshold ([Table 4](#t4-ehp-118-1189){ref-type="table"}). With CRFs from the single-pollutant model in [@b16-ehp-118-1189], which did not control for PM~2.5~, O~3~-mortality estimates were approximately 25% lower, corresponding to the relative magnitudes of the CRFs. Applying the 56-ppb LCT from the threshold model reduced mortality estimates by approximately 75%. For PM~2.5~, RRs from [@b18-ehp-118-1189] are similar to the 1979--1983 and 1999--2000 average all-cause and lung cancer RRs from [@b24-ehp-118-1189] but are approximately 40% higher for cardiopulmonary mortality, thus causing a corresponding increase in our estimates when applied \[[Table 5](#t5-ehp-118-1189){ref-type="table"}; see also Supplemental Material, Table 2 (doi:10.1289/ehp.0901220)\]. Using RRs from [@b19-ehp-118-1189]---an extended reanalysis of the Harvard Six Cities cohort study that found significantly higher RRs than did [@b18-ehp-118-1189]---increased estimated cardiopulmonary and lung cancer mortalities by approximately 30% and 50%, respectively. With no LCT, applying HCTs of 30 μg/m^3^ and 50 μg/m^3^ decreased estimated mortalities by approximately 10% and 1%, with larger decreases estimated for Europe and Asia, where some modeled concentrations exceeded the upper threshold values.

Discussion and Conclusions
==========================

We estimated the global burden of mortality due to anthropogenic O~3~ and PM~2.5~ using a global atmospheric CTM and health impact functions. Anthropogenic O~3~ was associated with about 0.7 ± 0.3 million respiratory mortalities (1.1% ± 0.5% of all mortalities) and 6.3 ± 3.0 million YLL annually when we assumed no upper or lower concentration threshold. Anthropogenic PM~2.5~ was associated with about 3.5 ± 0.9 million cardiopulmonary (5.6% ± 1.4% of all mortalities) and 220,000 ± 80,000 lung cancer mortalities (0.4% ± 0.1% of all mortalities) annually when we assumed no threshold, corresponding to 30 ± 7.6 million YLL. Global mortalities were reduced by approximately 30% when we assumed LCTs of 33.3 ppb for O~3~ and 5.8 μg/m^3^ for PM~2.5~, the lowest measured levels in [@b16-ehp-118-1189] and [@b18-ehp-118-1189]. Estimated excess mortalities were densest in highly populated areas but also occurred in rural areas that have been affected by the increased regional or global background of air pollution since preindustrial times. These estimates based only on cardiopulmonary and lung cancer mortality may be conservative because O~3~ and PM~2.5~ may also affect other causes of mortality. In addition, to be consistent with the ACS study population, we included only the population ≥ 30 years of age, but evidence suggests that O~3~ and PM~2.5~ affect health negatively for all ages, including the very young \[see [@b30-ehp-118-1189] and references therein\].

Estimated PM~2.5~ mortalities were five times O~3~ mortalities, suggesting that PM~2.5~ is the dominant contributor to the global health burden of outdoor air pollution. To minimize double counting of mortalities, we applied long-term RRs for O~3~ and PM~2.5~ based on the same ACS cohort. PM~2.5~ RRs have been shown to be independent from O~3~ concentrations ([@b17-ehp-118-1189]), and we used O~3~ RRs from [@b16-ehp-118-1189] that controlled for PM~2.5~. Furthermore, [@b16-ehp-118-1189] and [@b18-ehp-118-1189] reported that PM~2.5~-related mortality was dominated by cardiovascular mortality, whereas O~3~ was primarily associated with respiratory mortality. The independence of the exposure--response relationships and the difference in dominant biological mechanisms of mortality for each pollutant imply that double counting is unlikely to be significant. If these implications are correct, O~3~ and PM~2.5~ mortalities may be summed together to yield total mortalities; otherwise, summing the results would overestimate total mortalities.

Mortality estimates were sensitive to concentration thresholds and concentration--mortality relationships, often changing by \> 50% of the estimated value under different assumptions. We assumed that the CRFs found by epidemiology studies conducted in North America apply globally, despite differences in health status, lifestyle, age structure, and medical care, and emphasize cause-specific mortality. The CRFs used here could also be subject to confounders, including temperature ([@b16-ehp-118-1189]). Although some evidence suggests differential toxicity of PM~2.5~ components ([@b10-ehp-118-1189]; [@b23-ehp-118-1189]), we assumed that all PM~2.5~ species exert effects similar to aggregated PM~2.5~, despite differences in PM~2.5~ composition throughout the world. These assumptions, although necessary because of limited data, may have substantial impacts on the results.

Using the same assumptions for CRFs ([@b24-ehp-118-1189] for 1979--1983) and LCTs \[7.5 μg/m^3^, applied to total PM~2.5~ in [@b5-ehp-118-1189], but here only to the species in our definition of PM~2.5~\], our mortality estimates for urban and rural areas ([Table 5](#t5-ehp-118-1189){ref-type="table"}) were approximately 50% higher than the previous estimate of 800,000 mortalities from urban air pollution reported by [@b5-ehp-118-1189]. The discrepancy results from two competing differences in methods. First, we included rural populations, which were excluded by [@b5-ehp-118-1189]. Because the urban population in [@b5-ehp-118-1189] is approximately 30% of the total global population, and air pollution has increased in rural regions, including rural populations suggests many more air pollution mortalities globally. Second, we used a coarse-resolution global CTM that spread emissions across large grid cells. Although rural O~3~ and PM~2.5~ were well simulated, the coarse resolution may suppress high urban PM~2.5~ concentrations, causing underestimates of PM~2.5~ mortalities. Compared with a previous U.S. estimate of 144,000 PM~2.5~ mortalities (all causes) found using a regional CTM ([@b31-ehp-118-1189]), our estimate of PM~2.5~ mortalities in North America is similar but slightly lower (by 2% for cardiopulmonary and lung cancer mortalities and 7% for all-cause mortalities). The coarse-resolution model may either overestimate or underestimate O~3~ pollution in urban areas because O~3~ precursors were diluted into a large volume. Previous studies have found that regional O~3~ can be overestimated by 13% at the resolution used here but that background concentrations are not greatly affected by resolution ([@b40-ehp-118-1189]). A finer-resolution model would capture urban populations and concentrations more accurately, but adequate resolution is not currently possible in global air quality models.

Despite these limitations, this study highlights regions where improvements to air quality may be particularly effective at reducing mortality related to air pollution. Previous estimates rank urban air pollution (PM~2.5~ only) as the 13th leading global mortality risk factor and third among environmental risks ([@b9-ehp-118-1189]). Our results suggest a larger burden of disease due to outdoor air pollution than was previously estimated but should be compared with other risk factors only when all are updated consistently. Future estimates of the global burden of air pollution on mortality should strive to combine information from global and regional models with rural and urban concentrations from measurements. These estimates should also incorporate CRFs from new studies on O~3~-- and PM~2.5~--mortality relationships that examine individual PM~2.5~ components, that are conducted in different parts of the world, that include populations of all ages, and that resolve relationships at low and high concentrations. In the future, global economic development will likely shift the disease burden from infectious disease and malnutrition to chronic conditions, which are more strongly affected by air pollution exposure. Although some countries have implemented policies to improve air quality, without further action the global burden of anthropogenic air pollution on mortality may be even larger in the future than is estimated for the present.
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![Estimated annual premature mortalities attributed to anthropogenic PM~2.5~ when no upper or lower concentration threshold is assumed, for cardiopulmonary mortalities per 1,000 km^2^ (*A*), rate of cardiopulmonary mortalities per 10^6^ people (*B*), lung cancer mortalities per 1,000 km^2^ (*C*), and rate of lung cancer mortalities per 10^6^ people (*D*).](ehp-118-1189f3){#f3-ehp-118-1189}

###### 

Population ≥ 30 years of age, average baseline mortality rates, and population-weighted average and range of the seasonal average (6-month) 1-hr daily maximum O~3~ concentrations and annual average PM~2.5~ concentrations from MOZART-2 simulations of preindustrial (1860) and present-day (2000) levels.

                  Pop ≥ 30[b](#tfn3-ehp-118-1189){ref-type="table-fn"} (billions)   Baseline mortality rates (%/year)[c](#tfn4-ehp-118-1189){ref-type="table-fn"}   O~3~ (ppb)[a](#tfn2-ehp-118-1189){ref-type="table-fn"}   PM~2.5~ (μg/m^3^)[a](#tfn2-ehp-118-1189){ref-type="table-fn"}                                                                         
  --------------- ----------------------------------------------------------------- ------------------------------------------------------------------------------- -------------------------------------------------------- --------------------------------------------------------------- ------- ------------ ------- ------------ ------ ------------ ------- ------------
  Africa          0.28                                                              0.206                                                                           0.739                                                    0.011                                                           23.32   11.4--31.9   54.46   20.2--71.5   0.92   0.28--3.19   7.50    0.50--13.9
  North America   0.27                                                              0.081                                                                           0.502                                                    0.071                                                           21.42   12.5--32.3   59.75   27.0--89.3   1.50   0.14--4.65   8.44    0.31--16.6
  Europe          0.44                                                              0.127                                                                           1.22                                                     0.056                                                           18.26   15.2--27.5   48.92   32.3--74.3   0.93   0.11--2.96   14.77   0.40--39.0
  Asia            1.8                                                               0.171                                                                           0.746                                                    0.037                                                           18.91   6.15--35.9   59.64   10.8--83.7   1.19   0.23--3.06   20.41   0.34--55.9
  South America   0.15                                                              0.121                                                                           0.515                                                    0.025                                                           18.44   12.2--35.8   44.59   22.3--90.3   1.00   0.33--3.89   6.35    0.40--13.9
  Oceania         0.02                                                              0.074                                                                           0.346                                                    0.035                                                           13.37   3.74--22.8   26.75   6.41--44.4   0.96   0.22--2.27   2.59    0.25--5.01
  World           2.9                                                               0.134                                                                           0.754                                                    0.042                                                           19.61   3.74--35.9   56.70   6.41--90.3   1.13   0.11--3.89   16.11   0.25--55.9

Abbreviations: CP, cardiopulmonary; LC, lung cancer; Pop, population. Data are average and range for the highest and lowest individual grid cells.

Simulated by [@b14-ehp-118-1189].

Population ≥ 30 years of age for the year 2006 from the LandScan database ([@b22-ehp-118-1189]).

Baseline mortality rates are country specific for the latest year after 2000 with data available ([@b38-ehp-118-1189]). Where country-specific rates after the year 2000 were not available, we back-calculated country-specific rates from regional rates for the year 2002.

###### 

Estimated annual mortalities ± 1 SD due to anthropogenic O~3~ and PM~2.5~, assuming natural background only or LCTs (33.3 ppb for O~3~ and 5.8 μg/m^3^ for PM~2.5~) (× 1,000).

                  O~3~ respiratory   PM~2.5~ cardiopulmonary   PM~2.5~ lung cancer                            
  --------------- ------------------ ------------------------- --------------------- ------------- ---------- ----------
  Africa          63 ± 34            45 ± 30                   154 ± 44              52 ± 33       3 ± 1      1 ± 1
  North America   35 ± 17            25 ± 15                   124 ± 37              65 ± 30       17 ± 7     10 ± 5
  Europe          41 ± 21            23 ± 17                   586 ± 149             383 ± 143     47 ± 17    31 ± 14
  Asia            543 ± 253          370 ± 220                 2,584 ± 618           1,991 ± 603   152 ± 53   122 ± 47
  South America   18 ± 9             8 ± 6                     48 ± 15               16 ± 9        2 ± 1      1 ± 1
  Oceania         1 ± 1              0 ± 0                     2 ± 1                 0 ± 0         0 ± 0      0 ± 0
  World           700 ± 335          470 ± 288                 3,499 ± 864           2,506 ± 816   222 ± 80   164 ± 68

SDs reflect uncertainty in the CRF and simulated present-day concentrations (SD = 25% of simulated concentration).

###### 

Estimated annual YLL ± 1 SD due to anthropogenic O~3~ and PM~2.5~, assuming the natural background or LCTs (33.3 ppb for O~3~ and 5.8 μg/m^3^ for PM~2.5~) (× 1,000).

                  O~3~ respiratory   PM~2.5~ cardiopulmonary   PM~2.5~ lung cancer                                  
  --------------- ------------------ ------------------------- --------------------- ---------------- ------------- -------------
  Africa          901 ± 486          644 ± 429                 1,694 ± 484           572 ± 363        40 ± 13       13 ± 13
  North America   285 ± 138          203 ± 122                 804 ± 240             421 ± 194        152 ± 62      89 ± 45
  Europe          243 ± 125          136 ± 101                 4,336 ± 1,103         2,834 ± 1,058    472 ± 171     311 ± 141
  Asia            4,322 ± 2,014      2,945 ± 1,751             20,620 ± 4,932        15,888 ± 4,812   1,594 ± 556   1,280 ± 493
  South America   137 ± 68           61 ± 46                   365 ± 114             122 ± 68         19 ± 10       10 ± 10
  Oceania         7 ± 7              0 ± 0                     11 ± 6                0 ± 0            0 ± 0         0 ± 0
  World           6,251 ± 2,992      4,197 ± 2,572             27,607 ± 6,817        19,772 ± 6,438   2,169 ± 782   1,602 ± 664

SDs reflect uncertainty in the CRF and simulated present-day concentrations (SD = 25% of simulated concentration).

###### 

Estimated annual global O~3~ mortalities (mean ± 1 SD) using CRFs from the multipollutant model (in which PM~2.5~ was controlled) and single-pollutant model in [@b16-ehp-118-1189], and LCTs (×1,000).

                                                                Cardiopulmonary   Respiratory
  ------------------------------------------------------------- ----------------- --------------------
  Multipollutant model                                          ---               700 ± 335
   LCT = 25 ppb                                                 ---               605 ± 317 (−13.6%)
   LCT = 33.3 ppb                                               ---               470 ± 288 (−32.9%)
  Single-pollutant model                                        1,076 ± 493       524 ± 252 (−25.1%)
   LCT = 25 ppb                                                 925 ± 467         452 ± 238 (−35.4%)
   LCT = 33.3 ppb                                               705 ± 423         350 ± 215 (−50.0%)
  Threshold model[a](#tfn8-ehp-118-1189){ref-type="table-fn"}                     
   LCT = 56 ppb                                                 ---               178 ± 187 (−74.6%)

Data in parentheses are percentage change from estimates assuming CRFs from [@b16-ehp-118-1189] multipollutant model with no LCT (top row). Uncertainty is from the CRF and simulated present-day concentrations (SD = 25% of simulated concentration).

Calculated using the CRF (0.00432 ppb^−1^) and corresponding standard error (0.00121 ppb^−1^) for respiratory mortality when a threshold of 56 ppb is included in the O~3~-mortality model ([@b16-ehp-118-1189]). Although [@b16-ehp-118-1189] found that no threshold model was clearly a better fit to the data than a linear representation of the overall O~3~--mortality association, a threshold of 56 ppb was close to statistical significance (*p* = 0.06).

###### 

Estimated annual global PM~2.5~ mortalities (mean ± 1 SD) using alternative CRFs with and without LCTs and HCTs (×1,000).

                                                                                 Mortality                                          
  ------------------------------------------------------------------------------ ------------------------- ------------------------ --------------------
  [@b18-ehp-118-1189]                                                            3,381 ± 986               3,499 ± 864              222 ± 80
   LCT = 5.8 μg/m^3^                                                             2,378 ± 876 (−29.7%)      2,506 ± 816 (−28.4%)     164 ± 68 (−26.1%)
   LCT = 7.5 μg/m^3^                                                             2,077 ± 822 (−38.6%)      2,201 ± 780 (−37.1%)     146 ± 64 (−34.2%)
   HCT = 30 μg/m^3^                                                              3,059 ± 774 (−9.5%)       3,205 ± 676 (−8.4%)      201 ± 68 (−9.5%)
   HCT = 50 μg/m^3^                                                              3,338 ± 940 (−1.3%)       3,464 ± 826 (−1.0%)      219 ± 78 (−1.4%)
  [@b24-ehp-118-1189], 1979--1983[a](#tfn10-ehp-118-1189){ref-type="table-fn"}   2,333 ± 1,196 (−31.0%)    1,800 ± 742 (−48.6%)     139 ± 72 (−37.4%)
  [@b19-ehp-118-1189][b](#tfn11-ehp-118-1189){ref-type="table-fn"}               7,714 ± 2,736 (+128.2%)   4,549 ± 1,439 (+30.0%)   336 ± 198 (+51.4%)

Data in parentheses are percentage change from estimates assuming CRFs from [@b18-ehp-118-1189] and no LCT or HCT (top row). Uncertainty is from the CRF and simulated present-day concentrations (SD = 25% of simulated concentration).

[@b24-ehp-118-1189] reported RR estimates for two time periods (1979--1983 and 1999--2000) and for the integrated average of both. The RR estimates for 1979--1983 were more conservative than those from 1999--2000 and the integrated average. See Supplemental Material, Table 2 (doi:10.1289/ehp.0901220), for results from the average of both time periods and with concentration thresholds.

[@b19-ehp-118-1189] extended the follow-up of the Harvard Six Cities adult cohort study for 8 years and found significantly higher RR estimates for overall mortality than did the original study or [@b18-ehp-118-1189]. See Supplemental Material, Table 2 (doi:10.1289/ehp.0901220), for results with concentration thresholds.
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